Lunken Lab Biobank, Canada
Objective: The biobank is designed to support translational and clinical research focused on inflammatory bowel disease (IBD). It enables the investigation of microbiome-related aspects of IBD, including disease progression, treatment response, and biomarker discovery. To enable investigation of these aspects, the biobank will collect and store de-identified fecal, mucosal, and tissue samples from IBD patients during different phases of their disease as well as non-IBD controls. The purpose of the biobank is to create a comprehensive resource that reflects the IBD patient population in British Columbia, Canada. To achieve this, the target enrollment may include patients of varying age groups, genders, ethnicities, and disease stages (active, quiescent, control).
Registered Biobank Name | Lunken Lab Biobank |
Biobank Leader | Gurpreet Kaur |
Country | Canada |
Email for biobank inquiries | gk1522@mail.ubc.ca |
Principal Investigator | Dr. Genelle Lunken |
User Type
|
Poly - Collection aimed at supporting undetermined, multiple users with ethics approved research projects, through a defined access/application mechanism. |